PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals Inc's other long-term assets for the quarter that ended in Sep. 2014 was $0.16 Mil.
Progenics Pharmaceuticals Inc's quarterly other long-term assets declined from Mar. 2014 ($2.37 Mil) to Jun. 2014 ($2.37 Mil) and declined from Jun. 2014 ($2.37 Mil) to Sep. 2014 ($0.16 Mil).
Progenics Pharmaceuticals Inc's annual other long-term assets increased from Dec. 2011 ($3.53 Mil) to Dec. 2012 ($5.44 Mil) but then declined from Dec. 2012 ($5.44 Mil) to Dec. 2013 ($2.37 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Progenics Pharmaceuticals Inc Annual Data
|Other Long-Term Assets||1.52||7.94||23.86||40.50||22.58||5.66||4.86||3.53||5.44||2.37|
Progenics Pharmaceuticals Inc Quarterly Data
|Other Long-Term Assets||3.44||3.44||5.44||3.30||2.36||2.36||2.37||2.37||2.37||0.16|